130 related articles for article (PubMed ID: 10087976)
1. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
Moiseenko VM; Blinov NN; Semiglazov VV; Konstantinova MM; Trishkina EA
Vopr Onkol; 1998; 44(6):725-8. PubMed ID: 10087976
[TBL] [Abstract][Full Text] [Related]
2. [An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].
Poliakov PIu; Larionova NA; Bychenkov OA; Moc'kin VG
Vopr Onkol; 1999; 45(3):311-3. PubMed ID: 10443239
[TBL] [Abstract][Full Text] [Related]
3. [The effects of clodronate for the pain treatment of bone metastasis due to prostate cancer].
Ozyuvaci E; Altan A; Demir C
Agri; 2005 Jan; 17(1):49-53. PubMed ID: 15791501
[TBL] [Abstract][Full Text] [Related]
4. Disodium clodronate in the treatment of pain due to bone metastases.
Luzzani M; Vidili MG; Rissotto R; Nobile MT; Beghè F; Rosso R; Gottlieb A
Int J Clin Pharmacol Res; 1990; 10(4):243-6. PubMed ID: 2150406
[TBL] [Abstract][Full Text] [Related]
5. The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
Kylmälä T; Tammela TL; Lindholm TS; Seppänen J
Ann Chir Gynaecol; 1994; 83(4):316-9. PubMed ID: 7537482
[TBL] [Abstract][Full Text] [Related]
6. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.
Heidenreich A; Hofmann R; Engelmann UH
J Urol; 2001 Jan; 165(1):136-40. PubMed ID: 11125382
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain.
Ernst DS; Brasher P; Hagen N; Paterson AH; MacDonald RN; Bruera E
J Pain Symptom Manage; 1997 Jun; 13(6):319-26. PubMed ID: 9204651
[TBL] [Abstract][Full Text] [Related]
8. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study.
Varenna M; Zucchi F; Ghiringhelli D; Binelli L; Bevilacqua M; Bettica P; Sinigaglia L
J Rheumatol; 2000 Jun; 27(6):1477-83. PubMed ID: 10852274
[TBL] [Abstract][Full Text] [Related]
9. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer and bone metastases. The effect of clodronate.
Kylmälä T
Ann Chir Gynaecol; 1998; 87(1):59-60. PubMed ID: 9598233
[No Abstract] [Full Text] [Related]
11. Clodronate in the management of bone metastases: a clinical study of 91 patients.
Serkies K; Jereczek-Fossa B; Badzio A; Jassem J
Neoplasma; 1999; 46(5):317-22. PubMed ID: 10665850
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease.
Jagdev SP; Purohit P; Heatley S; Herling C; Coleman RE
Ann Oncol; 2001 Oct; 12(10):1433-8. PubMed ID: 11762816
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate].
Heidenreich A
Urologe A; 1997 Nov; 36(6):568. PubMed ID: 9487597
[No Abstract] [Full Text] [Related]
14. A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).
Dearnaley DP; Sydes MR; Mason MD; Stott M; Powell CS; Robinson AC; Thompson PM; Moffat LE; Naylor SL; Parmar MK;
J Natl Cancer Inst; 2003 Sep; 95(17):1300-11. PubMed ID: 12953084
[TBL] [Abstract][Full Text] [Related]
15. Disodium clodronate in painful nonresponsive periarthropathy of the hip.
Monteforte P; Molfetta L; Grillo G; Brignone A; Rovetta G
Int J Tissue React; 2000; 22(4):111-5. PubMed ID: 11199340
[TBL] [Abstract][Full Text] [Related]
16. [Metastatic bone lesions in solid tumors and possible use of clodronate (Bonephos) in clinical oncology].
Moiseenko VM; Blinov NN
Vopr Onkol; 1996; 42(2):17-30. PubMed ID: 8815629
[No Abstract] [Full Text] [Related]
17. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
Brown JE; McCloskey EV; Dewar JA; Body JJ; Cameron DA; Harnett AN; Ruutu M; Purohit OP; Tähtelä R; Coleman RE
Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
[TBL] [Abstract][Full Text] [Related]
18. Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible.
Montonen M; Kalso E; Pylkkären L; Lindströrm BM; Lindqvist C
Int J Oral Maxillofac Surg; 2001 Aug; 30(4):313-7. PubMed ID: 11518354
[TBL] [Abstract][Full Text] [Related]
19. Periarticular bone alterations in chronic antigen-induced arthritis: free and liposome-encapsulated clodronate prevent loss of bone mass in the secondary spongiosa.
Oelzner P; Bräuer R; Henzgen S; Thoss K; Wünsche B; Hersmann G; Abendroth K; Kinne RW
Clin Immunol; 1999 Jan; 90(1):79-88. PubMed ID: 9884355
[TBL] [Abstract][Full Text] [Related]
20. [Clodronate in treatment of tumor osteopathy. Evaluation in tumor patients with bone metastases or hypercalcemia].
Voigtmann R; Kirstein A
Fortschr Med; 1994 Feb; 112(4):43-6. PubMed ID: 7512066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
